Stock Movers cover image

United Health Sinks on Earnings; Eli Lilly's Drug Pop; Hertz's Rise Continues

Stock Movers

00:00

Eli Lilly's Breakthrough and Alcoa's Tariff Troubles

This chapter explores the major advancements in the pharmaceutical sector through Eli Lilly's successful phase three trial of an oral weight reduction pill, which boosted their stock. Conversely, it addresses the difficulties Alcoa faces with new tariffs that have negatively impacted their profitability and stock value.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app